http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36624586

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1512
issn 1520-4804
0022-2623
issueIdentifier 2
pageRange 1500-1512
publicationName Journal of Medicinal Chemistry
startingPage 1500
bibliographicCitation Mfuh AM, Boerth JA, Bommakanti G, Chan C, Chinn AJ, Code E, Fricke PJ, Giblin KA, Gohlke A, Hansel C, Hariparsad N, Hughes SJ, Jin M, Kantae V, Kavanagh SL, Lamb ML, Lane J, Moore R, Puri T, Quinn TR, Reddy I, Robb GR, Robbins KJ, Gancedo Rodrigo M, Schimpl M, Singh B, Singh M, Tang H, Thomson C, Walsh JJ, Ware J, Watson IDG, Ye MW, Wrigley GL, Zhang AX, Zhang Y, Grimster NP. Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors. J Med Chem. 2024 Jan 25;67(2):1500–12. doi: 10.1021/acs.jmedchem.3c02083. PMID: 38227216.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8541-0882
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d72e2b80b3573ae05f373122b94a8b6e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8619-1455
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9839f4f0078b3ee953e2179f7f87efcc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_561e13ace800df356e581471eb96d6fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40cbc68616d1f66a98adbd551c1e70e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3005-8065
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2ddc163f07220979f6794498a0b5c9a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7288b00622674cc89abdcea7b20ceb0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef5086dc76f01bf04dd90ed57f699326
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_074ef792c2581c64484804d93cc1b0e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64f7842ff0861ce358c3aacc47f5d799
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2284-5250
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9ba4d115b6d22c26b50c72203209681
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6290-5329
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3160-1397
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4531-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59115852c3e89106343a0bd025a541d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b23750ca726dee49187973387e50f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a41905057e29bc5db03ab8d2fc9a783b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c3d1b056cc421070d6853565c5dd400
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2446-6326
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3508-3240
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_134c5267f633289a2b2cb9e26fb039b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_842b48aa6bb0a228dc4338c675b3ada3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2828-5768
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9f98e126186fa159343604e8d8c9249
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9a2448cdcf866afa0f37a5d48ac7d14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0287-4337
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0088-1250
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47dfaf363c20485e9963cef0ce280b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_973697cfc8c6a7641db7a55c53bb60c5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0406-2404
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0009-0002-1880-785X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c50e6e5d0f51e61e777115fea9deedf2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2b36165e1515ef876949eddca67dfb3
date 2024-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/38227216
https://doi.org/10.1021/acs.jmedchem.3c02083
isPartOf https://portal.issn.org/resource/ISSN/1520-4804
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4938
https://portal.issn.org/resource/ISSN/0022-2623
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors
discusses http://id.nlm.nih.gov/mesh/M0369737
http://id.nlm.nih.gov/mesh/M0188097
http://id.nlm.nih.gov/mesh/M0446168
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D044767Q000378
http://id.nlm.nih.gov/mesh/D050721Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D010766
http://id.nlm.nih.gov/mesh/D013601Q000378
http://id.nlm.nih.gov/mesh/D025801Q000378

Total number of triples: 64.